Secisbp2 is essential for embryonic development and enhances selenoprotein expression

Antioxidants and Redox Signaling

Volumn 21, Issue 6, 2014, Pages 835-849

  Seeher, Sandra ^a,b   Atassi, Tarik ^c   Mahdi, Yassin ^a,b   Carlson, Bradley A ^d   Braun, Doreen ^a,b   Wirth, Eva K ^a   Klein, Marc O ^e   Reix, Nathalie ^f   Miniard, Angela C ^c   Schomburg, Lutz ^a   Hatfield, Dolph L ^d   Driscoll, Donna M ^c   Schweizer, Ulrich ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BINDING PROTEIN; CD36 ANTIGEN; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE A4; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; HEME OXYGENASE 1; MESSENGER RNA; NUCLEOLIN; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOCYSTEINE; SELENOCYSTEINE INSERTION SEQUENCE BINDING PROTEIN 2; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THYROID HORMONE; TRANSCRIPTION FACTOR NRF2; TRANSFER RNA; UNCLASSIFIED DRUG; RNA BINDING PROTEIN; SECIS-BINDING PROTEIN 2, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLASTOCYST; BODY WEIGHT; BRAIN; CODON; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EXON; FEMALE; GASTRULATION; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; GENE TARGETING; KIDNEY; LIVER; LIVER CELL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RNA TRANSLATION; SELENIUM BLOOD LEVEL; STOP CODON; TESTIS; TRANSGENIC MOUSE; WESTERN BLOTTING; ALLELE; ALTERNATIVE RNA SPLICING; ANIMAL; GENE EXPRESSION REGULATION; GENE LOCUS; GENE ORDER; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; MUTATION;

ALLELES; ALTERNATIVE SPLICING; ANIMALS; EMBRYONIC DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE ORDER; GENE SILENCING; GENE TARGETING; GENETIC LOCI; GENOTYPE; HEPATOCYTES; LIVER; MALE; MICE; MICE, KNOCKOUT; MUTATION; NF-E2-RELATED FACTOR 2; RNA, MESSENGER; RNA-BINDING PROTEINS; SELENOPROTEINS;

EID: 84904602887     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5358     Document Type: Article

References (61)

1. Azevedo MF, Barra GB, Naves LA, Ribeiro Velasco LF, Godoy Garcia CP, de Castro LC, Amato AA, Miniard A, Driscoll D, Schomburg L, and Assis Rocha NF. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 95: 4066-4071, 2010
2. Baron C, Heider J, and Böck A. Interaction of translation factor SELB with the formate dehydrogenase H selenopolypeptide mRNA. Proc Natl Acad Sci U S A 90: 4181-4185, 1993
3. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, and Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3¢ untranslated region. Nature 353: 273-276, 1991
4. Bianco AC, Salvatore D, Gereben B, Berry MJ, and Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89, 2002
5. Bondareva AA, Capecchi MR, Iverson SV, Li Y, Lopez NI, Lucas O, Merrill GF, Prigge JR, Siders AM, Wakamiya M, Wallin SL, and Schmidt EE. Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. Free Radic Biol Med 43: 911-923, 2007
6. Bö sl MR, Takaku K, Oshima M, Nishimura S, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci U S A 94: 5531-5534, 1997
7. Braun D, Wirth EK, Wohlgemuth F, Reix N, Klein MO, Grüters A, Köhrle J, and Schweizer U. Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8. Biochem J 439: 249-255, 2011
8. Bubenik JL and Driscoll DM. Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequencebinding protein 2. J Biol Chem 282: 34653-34662, 2007
9. Budiman ME, Bubenik JL, Miniard AC, Middleton LM, Gerber CA, Cash A, and Driscoll DM. Eukaryotic initiation factor 4a3 is a selenium-regulated RNA-binding protein that selectively inhibits selenocysteine incorporation. Mol Cell 35: 479-489, 2009
10. Caban K, Kinzy SA, and Copeland PR. The L7Ae RNA binding motif is a multifunctional domain required for the ribosome-dependent Sec incorporation activity of Sec insertion sequence binding protein 2. Mol Cell Biol 27: 6350-6360, 2007
11. Carlson BA, Moustafa ME, Sengupta A, Schweizer U, Shrimali R, Rao M, Zhong N, Wang S, Feigenbaum L, Lee BJ, Gladyshev VN, and Hatfield DL. Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34. J Biol Chem 282: 32591-32602, 2007
12. Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, Gladyshev VN, and Hatfield DL. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 279: 8011-8017, 2004
13. Carlson BA, Xu XM, Gladyshev VN, and Hatfield DL. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem 280: 5542-5548, 2005
14. Chavatte L, Brown BA, and Driscoll DM. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat Struct Mol Biol 12: 408-416, 2005
15. Chiu-Ugalde J, Theilig F, Behrends T, Drebes J, Sieland C, Subbarayal P, Köhrle J, Hammes A, Schomburg L, and Schweizer U. Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain. Biochem J 431: 103-111, 2010
16. Conrad M and Schweizer U. Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid Redox Signal 12: 851-865, 2010
17. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, and Driscoll DM. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J 19: 306-314, 2000
18. Donovan J, Caban K, Ranaweera R, Gonzalez-Flores JN, and Copeland PR. A novel protein Domain induces high affinity selenocysteine insertion sequence binding and elongation factor recruitment. J Biol Chem 283: 35129-35139, 2008
19. Donovan J and Copeland PR. Evolutionary history of selenocysteine incorporation from the perspective of SECIS binding proteins. BMC Evol Biol 9: 229, 2009
20. Dumitrescu AM, Di Cosmo C, Liao XH, Weiss RE, and Refetoff S. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 12: 905-920, 2010
21. Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, Boran G, Schomburg L, Weiss RE, and Refetoff S. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37: 1247-1252, 2005
22. Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, and Krol A. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J 19: 4796-4805, 2000
23. Handy DE, Hang G, Scolaro J, Metes N, Razaq N, Yang Y, and Loscalzo J. Aminoglycosides decrease glutathione peroxidase-1 activity by interfering with selenocysteine incorporation. J Biol Chem 281: 3382-3388, 2006
24. Hatfield DL, Carlson BA, Xu XM, Mix H, and Gladyshev VN. Selenocysteine incorporation machinery and the role of selenoproteins in Development and health. Prog Nucleic Acid Res Mol Biol 81: 97-142, 2006
25. Hill KE, Wu S, Motley AK, Stevenson TD, Winfrey VP, Capecchi MR, Atkins JF, and Burk RF. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J Biol Chem 287: 40414-40424, 2012
26. Holmgren A and Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995
27. Imai H, Hirao F, Sakamoto T, Sekine K, Mizukura Y, Saito M, Kitamoto T, Hayasaka M, Hanaoka K, and Nakagawa Y. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun 305: 278-286, 2003
28. Jakupoglu C, Przemeck GK, Schneider M, Moreno SG, Mayr N, Hatzopoulos AK, de Angelis MH, Wurst W, Bornkamm GW, Brielmeier M, and Conrad M. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol 25: 1980-1988, 2005
29. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, and Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439-1443, 2003
30. Latrèche L, Jean-Jean O, Driscoll DM, and Chavatte L. Novel structural determinants in human SECIS elements modulate the translational recoding of UGA as selenocysteine. Nucleic Acids Res 37: 5868-5880, 2009
31. Leinfelder W, Forchhammer K, Veprek B, Zehelein E, and Böck A. In vitro synthesis of selenocysteinyl-TRNA(UCA) from seryl-TRNA(UCA): Involvement and characterization of the selD gene product. Proc Natl Acad Sci U S A 87: 543-547, 1990
32. Lu J, Zhong L, Lonn ME, Burk RF, Hill KE, and Holmgren A. Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J 23: 2394-2402, 2009
33. Miniard AC, Middleton LM, Budiman ME, Gerber CA, and Driscoll DM. Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res 38: 4807-4820, 2010
34. Moghadaszadeh B, Petit N, Jaillard C, Brockington M, Roy SQ, Merlini L, Romero N, Estournet B, Desguerre I, Chaigne D, Muntoni F, Topaloglu H, and Guicheney P. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 29: 17-18, 2001
35. Moriarty PM, Reddy CC, and Maquat LE. Selenium deficiency reduces the abundance of mRNA for Se-dependent glutathione peroxidase 1 by a UGA-dependent mechanism likely to be nonsense codon-mediated decay of cytoplasmic mRNA. Mol Cell Biol 18: 2932-2939, 1998
36. Renko K, Werner M, Renner-Muller I, Cooper TG, Yeung CH, Hollenbach B, Scharpf M, Köhrle J, Schomburg L, and Schweizer U. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem J 409: 741-749, 2008
37. Schneider M, Forster H, Boersma A, Seiler A, Wehnes H, Sinowatz F, Neumuller C, Deutsch MJ, Walch A, Hrabe d A, Wurst W, Ursini F, Roveri A, Maleszewski M, Maiorino M, and Conrad M. Mitochondrial glutathione peroxidase 4 disruption causes male infertility. FASEB J 23: 3233-3242, 2009
38. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, and Galton VA. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15: 2137-2148, 2001
39. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St Germain DL, and Galton VA. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147: 580-589, 2006
40. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, and Chatterjee K. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein Deficiency disorder in humans. J Clin Invest 120: 4220-4235, 2010
41. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, and Köhrle J. Gene disruption Discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397-402, 2003
42. Schweizer U, Dehina N, and Schomburg L. Disorders of selenium metabolism and selenoprotein function. Curr Opin Pediatr 23: 429-435, 2011
43. Schweizer U, Streckfuss F, Pelt P, Carlson BA, Hatfield DL, Köhrle J, and Schomburg L. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J 386: 221-226, 2005
44. Seeher S, Mahdi Y, and Schweizer U. Post-Transcriptional control of selenoprotein biosynthesis. Curr Protein Pept Sci 13: 337-346, 2012
45. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, and Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/ 15-lipoxygenase dependent- And AIF-mediated cell death. Cell Metab 8: 237-248, 2008
46. Sengupta A, Carlson BA, Weaver JA, Novoselov SV, Fomenko DE, Gladyshev VN, and Hatfield DL. A functional link between housekeeping selenoproteins and phase II enzymes. Biochem J 413: 151-161, 2008
47. Shen Q, Fan L, and Newburger PE. Nuclease sensitive element binding protein 1 associates with the selenocysteine insertion sequence and functions in mammalian selenoprotein translation. J Cell Physiol 207: 775-783, 2006
48. Shen Q, Wu R, Leonard JL, and Newburger PE. Identification and molecular cloning of a human selenocysteine insertion sequence-binding protein. A bifunctional role for DNA-binding protein B. J Biol Chem 273: 5443-5446, 1998
49. Shi ZZ, Osei-Frimpong J, Kala G, Kala SV, Barrios RJ, Habib GM, Lukin DJ, Danney CM, Matzuk MM, and Lieberman MW. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci U S A 97: 5101-5106, 2000
50. Squires JE, Stoytchev I, Forry EP, and Berry MJ. SBP2 binding affinity is a major determinant in Differential selenoprotein mRNA translation and sensitivity to nonsensemediated decay. Mol Cell Biol 27: 7848-7855, 2007
51. Srinivasan G, James CM, and Krzycki JA. Pyrrolysine encoded by UAG in Archaea: Charging of a UAG-decoding specialized tRNA. Science 296: 1459-1462, 2002
52. Streckfuss F, Hamann I, Schomburg L, Michaelis M, Sapin R, Klein MO, Köhrle J, and Schweizer U. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochem Biophys Res Commun 337: 739-745, 2005
53. Sunde RA, Raines AM, Barnes KM, and Evenson JK. Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci Rep 29: 329-338, 2009
54. Walczak R, Westhof E, Carbon P, and Krol A. A novel RNA structural motif in the selenocysteine insertion element of eukaryotic selenoprotein mRNAs. RNA 2: 367-379, 1996
55. Winkler R, Benz V, Clemenz M, Bloch M, Foryst-Ludwig A, Wardat S, Witte N, Trappiel M, Namsolleck P, Mai K, Spranger J, Matthias G, Roloff T, Truee O, Kappert K, Schupp M, Matthias P, and Kintscher U. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes 61: 513-523, 2012
56. Wu R, Shen Q, and Newburger PE. Recognition and binding of the human selenocysteine insertion sequence by nucleolin. J Cell Biochem 77: 507-516, 2000
57. Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, and Hatfield DL. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol 5: E4, 2007
58. Xu XM, Turanov AA, Carlson BA, Yoo MH, Everley RA, Nandakumar R, Sorokina I, Gygi SP, Gladyshev VN, and Hatfield DL. Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc Natl Acad Sci U S A 107: 21430-21434, 2010
59. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta L, Richardson A, and Prolla TA. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 34: 496-502, 2003
60. Yuan J, Palioura S, Salazar JC, Su D, O'Donoghue P, Hohn MJ, Cardoso AM, Whitman WB, and Söll D. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci U S A 103: 18923-18927, 2006
61. Zinoni F, Birkmann A, Leinfelder W, and Böck A. Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc Natl Acad Sci U S A 84: 3156-3160, 1987.